PubMed · 1975 · 72 citations · 0 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic Nuclear MedicineDiagnostic RadiologyRadiopharmaceuticalsRenal ImagingRenal Mass CharacterizationRenal Mass EvaluationRenal Nuclear ImagingRenal ScintigraphyAdult Renal ScintigraphyDimercaptosuccinic Acid ScanDmsa Renal ScanKit FormulationRenal Nuclear ScintigraphyRenal Parenchymal Disease ImagingTc-99m Dimercaptosuccinic Acid ScintigraphyTechnetium-99m Dimercaptosuccinic Acid Imaging
Results are reported from the clinical evaluation of a new radiopharmaceutical for renal imaging, 99mTc-DMSA (dimercaptosuccinic acid). Sixty-five patients were studied and six of these patients' scintiphotos are illustrated. The physical characteristics of 99mTc and the mercurial-like kinetics of the chelate produced high-resolution scintiphotos of the renal parenchyma in patients of all ages and with a variety of disease entities. The commercial availability of the material in kit form permits its usage in all nuclear medicine facilities.